vs
GLOBUS MEDICAL INC（GMED）与Ryman Hospitality Properties, Inc.（RHP）财务数据对比。点击上方公司名可切换其他公司
GLOBUS MEDICAL INC的季度营收约是Ryman Hospitality Properties, Inc.的1.1倍（$826.4M vs $737.8M），GLOBUS MEDICAL INC净利率更高（17.0% vs 10.1%，领先6.9%），GLOBUS MEDICAL INC同比增速更快（25.7% vs 13.9%），GLOBUS MEDICAL INC自由现金流更多（$202.4M vs $58.5M），过去两年Ryman Hospitality Properties, Inc.的营收复合增速更高（18.2% vs 16.7%）
Globus Medical是总部位于美国宾夕法尼亚州奥杜邦的上市骨科医疗器械企业，专注于相关产品的设计、研发与商业化，助力外科医生为肌肉骨骼系统疾病患者提供治疗方案，促进患者康复。
莱曼酒店地产是一家主营酒店、度假村、娱乐及媒体业务的企业，得名于旗下位于田纳西州纳什维尔的国家历史地标莱曼礼堂。公司历史可追溯至曾为俄克拉荷马出版公司子公司时期，1983年收购WSM公司后奠定现代业务基础，同时将知名演出IP大奥普里等核心资产纳入麾下。
GMED vs RHP — 直观对比
营收规模更大
GMED
是对方的1.1倍
$737.8M
营收增速更快
GMED
高出11.8%
13.9%
净利率更高
GMED
高出6.9%
10.1%
自由现金流更多
GMED
多$143.9M
$58.5M
两年增速更快
RHP
近两年复合增速
16.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $826.4M | $737.8M |
| 净利润 | $140.6M | $74.5M |
| 毛利率 | 68.4% | 41.4% |
| 营业利润率 | 20.5% | 19.4% |
| 净利率 | 17.0% | 10.1% |
| 营收同比 | 25.7% | 13.9% |
| 净利润同比 | 430.4% | 3.0% |
| 每股收益（稀释后） | $1.01 | $1.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMEDRHP
| Q4 25 | $826.4M | $737.8M | ||
| Q3 25 | $769.0M | $592.5M | ||
| Q2 25 | $745.3M | $659.5M | ||
| Q1 25 | $598.1M | $587.3M | ||
| Q4 24 | $657.3M | $647.6M | ||
| Q3 24 | $625.7M | $550.0M | ||
| Q2 24 | $629.7M | $613.3M | ||
| Q1 24 | $606.7M | $528.3M |
净利润GMEDRHP
| Q4 25 | $140.6M | $74.5M | ||
| Q3 25 | $119.0M | $34.9M | ||
| Q2 25 | $202.8M | $71.8M | ||
| Q1 25 | $75.5M | $63.0M | ||
| Q4 24 | $26.5M | $72.3M | ||
| Q3 24 | $51.8M | $59.0M | ||
| Q2 24 | $31.8M | $100.8M | ||
| Q1 24 | $-7.1M | $42.8M |
毛利率GMEDRHP
| Q4 25 | 68.4% | 41.4% | ||
| Q3 25 | 67.2% | 40.9% | ||
| Q2 25 | 66.6% | 49.7% | ||
| Q1 25 | 67.3% | 44.4% | ||
| Q4 24 | 59.9% | 40.4% | ||
| Q3 24 | 56.8% | 43.1% | ||
| Q2 24 | 58.7% | 48.4% | ||
| Q1 24 | 60.2% | 41.5% |
营业利润率GMEDRHP
| Q4 25 | 20.5% | 19.4% | ||
| Q3 25 | 17.9% | 15.0% | ||
| Q2 25 | 10.2% | 21.1% | ||
| Q1 25 | 16.2% | 19.8% | ||
| Q4 24 | 9.2% | 18.6% | ||
| Q3 24 | 7.7% | 19.3% | ||
| Q2 24 | 7.9% | 27.4% | ||
| Q1 24 | 1.3% | 18.2% |
净利率GMEDRHP
| Q4 25 | 17.0% | 10.1% | ||
| Q3 25 | 15.5% | 5.9% | ||
| Q2 25 | 27.2% | 10.9% | ||
| Q1 25 | 12.6% | 10.7% | ||
| Q4 24 | 4.0% | 11.2% | ||
| Q3 24 | 8.3% | 10.7% | ||
| Q2 24 | 5.0% | 16.4% | ||
| Q1 24 | -1.2% | 8.1% |
每股收益（稀释后）GMEDRHP
| Q4 25 | $1.01 | $1.12 | ||
| Q3 25 | $0.88 | $0.53 | ||
| Q2 25 | $1.49 | $1.12 | ||
| Q1 25 | $0.54 | $1.00 | ||
| Q4 24 | $0.19 | $1.12 | ||
| Q3 24 | $0.38 | $0.94 | ||
| Q2 24 | $0.23 | $1.65 | ||
| Q1 24 | $-0.05 | $0.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $557.2M | $471.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.6B | $750.2M |
| 总资产 | $5.3B | $6.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GMEDRHP
| Q4 25 | $557.2M | $471.4M | ||
| Q3 25 | $18.8M | $483.3M | ||
| Q2 25 | — | $420.6M | ||
| Q1 25 | — | $413.9M | ||
| Q4 24 | $890.1M | $477.7M | ||
| Q3 24 | $71.9M | $534.9M | ||
| Q2 24 | $82.5M | $498.4M | ||
| Q1 24 | $80.4M | $465.3M |
股东权益GMEDRHP
| Q4 25 | $4.6B | $750.2M | ||
| Q3 25 | $4.4B | $758.5M | ||
| Q2 25 | $4.3B | $800.4M | ||
| Q1 25 | $4.1B | $531.5M | ||
| Q4 24 | $4.2B | $549.0M | ||
| Q3 24 | $4.1B | $551.9M | ||
| Q2 24 | $4.0B | $562.6M | ||
| Q1 24 | $3.9B | $529.9M |
总资产GMEDRHP
| Q4 25 | $5.3B | $6.2B | ||
| Q3 25 | $5.1B | $6.2B | ||
| Q2 25 | $5.0B | $6.1B | ||
| Q1 25 | $4.7B | $5.2B | ||
| Q4 24 | $5.3B | $5.2B | ||
| Q3 24 | $5.1B | $5.2B | ||
| Q2 24 | $5.0B | $5.1B | ||
| Q1 24 | $4.9B | $5.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $248.6M | $164.7M |
| 自由现金流经营现金流 - 资本支出 | $202.4M | $58.5M |
| 自由现金流率自由现金流/营收 | 24.5% | 7.9% |
| 资本支出强度资本支出/营收 | 5.6% | 14.4% |
| 现金转化率经营现金流/净利润 | 1.77× | 2.21× |
| 过去12个月自由现金流最近4个季度 | $588.8M | $232.4M |
8季度趋势，按日历期对齐
经营现金流GMEDRHP
| Q4 25 | $248.6M | $164.7M | ||
| Q3 25 | $249.7M | $205.2M | ||
| Q2 25 | $77.9M | $122.5M | ||
| Q1 25 | $177.3M | $98.2M | ||
| Q4 24 | $210.3M | $166.6M | ||
| Q3 24 | $203.7M | $218.1M | ||
| Q2 24 | $54.3M | $184.3M | ||
| Q1 24 | $52.4M | $7.5M |
自由现金流GMEDRHP
| Q4 25 | $202.4M | $58.5M | ||
| Q3 25 | $213.9M | $135.4M | ||
| Q2 25 | $31.3M | $53.0M | ||
| Q1 25 | $141.2M | $-14.5M | ||
| Q4 24 | $193.2M | $76.0M | ||
| Q3 24 | $161.7M | $85.7M | ||
| Q2 24 | $26.5M | $78.8M | ||
| Q1 24 | $23.8M | $-72.0M |
自由现金流率GMEDRHP
| Q4 25 | 24.5% | 7.9% | ||
| Q3 25 | 27.8% | 22.9% | ||
| Q2 25 | 4.2% | 8.0% | ||
| Q1 25 | 23.6% | -2.5% | ||
| Q4 24 | 29.4% | 11.7% | ||
| Q3 24 | 25.8% | 15.6% | ||
| Q2 24 | 4.2% | 12.9% | ||
| Q1 24 | 3.9% | -13.6% |
资本支出强度GMEDRHP
| Q4 25 | 5.6% | 14.4% | ||
| Q3 25 | 4.7% | 11.8% | ||
| Q2 25 | 6.2% | 10.5% | ||
| Q1 25 | 6.0% | 19.2% | ||
| Q4 24 | 2.6% | 14.0% | ||
| Q3 24 | 6.7% | 24.1% | ||
| Q2 24 | 4.4% | 17.2% | ||
| Q1 24 | 4.7% | 15.0% |
现金转化率GMEDRHP
| Q4 25 | 1.77× | 2.21× | ||
| Q3 25 | 2.10× | 5.88× | ||
| Q2 25 | 0.38× | 1.71× | ||
| Q1 25 | 2.35× | 1.56× | ||
| Q4 24 | 7.94× | 2.30× | ||
| Q3 24 | 3.93× | 3.70× | ||
| Q2 24 | 1.71× | 1.83× | ||
| Q1 24 | — | 0.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMED
| Other | $391.8M | 47% |
| Nevro Merger Agreement | $293.6M | 36% |
| Enabling Technologies | $141.0M | 17% |
RHP
| Hotel Other | $157.7M | 21% |
| Gaylord Opryland | $147.4M | 20% |
| Hotel Transient Rooms | $93.6M | 13% |
| Hotel Food And Beverage Outlets | $92.2M | 12% |
| Gaylord Palms | $88.2M | 12% |
| Jw Marriott Hill Country | $53.7M | 7% |
| Entertainment Admissions And Ticketing | $43.1M | 6% |
| Entertainment Food And Beverage | $38.1M | 5% |
| Entertainment Retail And Other | $28.3M | 4% |
| Ac Hotel | $2.4M | 0% |
